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Gene expression proﬁling of dedifferentiated human articular chondrocytes
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Objective: When primary chondrocytes are cultured in monolayer, they undergo dedifferentiation during
which they lose their phenotype and their capacity to form cartilage. Dedifferentiation is an obstacle for
cell therapy for cartilage degeneration. In this study, we aimed to systemically evaluate the changes in
gene expression during dedifferentiation of human articular chondrocytes to identify underlying
mechanisms.
Methods: RNA was isolated from monolayer-cultured primary human articular chondrocytes at serial
passages. Gene expression was analyzed by microarray. Based on the microarray analysis, relevant genes
and pathways were identiﬁed. Their functions in chondrocyte dedifferentiation were further
investigated.
Results: In vitro expanded human chondrocytes showed progressive changes in gene expression. Strik-
ingly, an overall decrease in total gene expression was detected, which was both gradual and cumulative.
DNA methylation was in part responsible for the expression downregulation of a number of genes. Genes
involved in many pathways such as the extracellular-signal-regulated kinase (ERK) and Bone morpho-
genetic protein (BMP) pathways exhibited signiﬁcant changes in expression. Inhibition of ERK pathway
did not show dramatic effects in counteracting dedifferentiation process. BMP-2 was able to decelerate
the dedifferentiation and reinforce the maintenance of chondrocyte phenotype in monolayer culture.
Conclusion: Our study not only improves our knowledge of the intricate signaling network regulating
maintenance of chondrocyte phenotype, but also contributes to improved chondrocyte expansion and
chondrogenic performance for cell therapy.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Articular chondrocytes maintain the articular cartilage homeo-
stasis by synthesis of extracellular matrix (ECM)molecules including
type II collagen (COL2) and proteoglycans1. The phenotype of dif-
ferentiated chondrocytes is unstable and rapidly lost with exposure
to inﬂammatory factors, as well as during monolayer culture2,3. This
process is designated dedifferentiation and is characterized by the
loss of ECM molecules such as COL24. Autologous chondrocyte im-
plantation (ACI) is the golden therapy for patients with focal lesions
of articular cartilage5,6. ACI consists of removal of a small piece of
intact articular cartilage, isolation and expansion of chondrocytes to
obtain sufﬁcient number of cells for implantation. DedifferentiationM. Karperien, Department of
e, Drienerlolaan 5, Enschede
31-53-489-2150.
rperien).
s Research Society International. Pof chondrocytes during in vitro expansion is a major obstacle in ACI.
The exact mechanism of the dedifferentiation remains elusive. This
study aims to provide systemic analysis of mechanisms of human
articular chondrocyte dedifferentiation.
Methods, results and discussion
Human articular chondrocytes were isolated from knee joints of
patients undergoing total knee replacement surgery for end stage
osteoarthritis (OA) (n ¼ 4, mean age  standard deviation (SD):
62.8  7.6) using 1 mg/ml collagenase II (SigmaeAldrich) prepared
in Dulbecco’s Modiﬁed Eagle Medium (DMEM) (Invitrogen) at 37C
overnight under agitation, and were seeded at a density of
25,000 cells/cm2 in DMEM supplemented with 10% fetal bovine
serum (FBS) and 1% penicillin-streptomycin (Invitrogen). Chon-
drocytes were cultured in monolayer up to passage 8 and assessed
at passage 0, 2, 4, 6 and 8. Chondrocytes showed typical phenotypic
changes during monolayer culture. Cells lost their round shape and
became ﬂattened (Fig. S1A). To test if dedifferentiated chondrocytesublished by Elsevier Ltd. All rights reserved.
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2 and 8 chondrocytes were cultured in pellets (200,000 cells per
well were seeded in a round-bottom 96-wells plate and centrifuged
for 3 min at 2000 rpm to form high-density micromass cell pellets)
in chondrogenic differentiation media (DMEM supplemented with
10% FBS, 1% penicillin-streptomycin, 0.2 mM ascorbic acid 2-
phosphate, 0.4 mM proline, 10 ng/ml transforming growth factor
(TGF)-b1) for 3 weeks and then subjected to histological analysis.
Cell pellets were ﬁxed with 10% formalin for 15 min and embedded
in parafﬁn using routine. Sections of 5 mmwere cut and stained for
sulfated glycosaminoglycans (GAGs) with alcian blue combined
with counterstaining of nuclear fast red to observe nuclei. Passage 2
cells were still able to produce a cartilage-speciﬁc ECM while pas-
sage 8 cells had lost their ability to regain chondrocyte character-
istics (Fig. S1B). These data suggest that after expansion for eight
passages human chondrocytes have lost their capacity to produce
cartilaginous matrixes at least in vitro.
For a comprehensive understanding of chondrocyte dediffer-
entiation, we analyzed global gene expression changes during
monolayer culture. RNA samples frompassage 0, 2, 4, 6, and 8 human
articular chondrocytes of four donors were isolated using Absolutely
RNAMiniprepKit (Agilent Technologies) and subjected tomicroarray
analysis. The Ambion Illumina total prep 96 kit was used to generate
biotinylated cRNA. 750 ngof the cRNAof each samplewas hybridized
onto Illumina HumanHT-12 v3 Expression BeadChips. BeadChips
were scanned using the Illumina iScan array scanner. Gene expres-
sion proﬁling was performed using Illumina’s Genomestudio
v. 2010.1 with default settings advised by Illumina. The raw ﬂuo-
rescence intensity values were normalized applying quantile nor-
malization. Differential gene expression was analyzed using
GeneSpring, version 11.5.1 (Agilent Technologies). Geneswith at least
a two-fold difference and signiﬁcantly differentially expressed ac-
cording to a one-way analysis of variance with a Benjaminie
Hochberg false discovery rate correction and TukeyHSD post-hoc
test, using a cut-off rate of P ¼ 0.05, were selected. Gene expression
levels were compared to that of passage 0 (P0). The raw andFig. 1. Whole genome gene expression analysis of dedifferentiating chondrocytes. (A) Ven
change at P2, P4 and P8 compared to P0 respectively of four donors. (B) Fold changes of all in
levels of each passage were compared to P0. The mean fold change is indicated by red line. (C
Average of differences between passages is indicated by red line. (D) Involvement of DNA m
with 2 mM 5-AzaC for 48 h mRNA levels were measured by qPCR. Data were expressed asnormalized data are deposited in the Gene Expression Omnibus
database (GSE42235). Table S1 shows all genes with at least a two-
fold change in expression at P8 compared to P0. 137 genes showed
over two-fold signiﬁcant change at passage 2 [Fig.1(A)]. Over time, an
increasing number of genes showed signiﬁcant differences. 93 genes
showed consistent changes through all passages compared to P0
[Fig. 1(A)]. Interestingly, the 10 most changed genes were almost all
down-regulated during all passages as compared to P0 (Table S2). In
agreement with this, the average of fold changes in gene expression
levels of all signiﬁcantly changed genes at each passage decreased
from P2 to P8 [Fig.1(B)]. When gene expression levels of one passage
were compared to those of the previous passage (e.g., P0eP2, P2eP4,
P4eP6, P6eP8), the average rate of decrease in expression level of the
subsequent passage appeared constant [Fig. 1(C)], indicating that the
dedifferentiation process is both gradual and cumulative.
Since more genes showed downregulation of expression during
chondrocyte dedifferentiation and DNA methylation is an epi-
genetic mechanism for gene expression silencing implicated in
chondrogenesis and cartilage degeneration7,8, we explored the role
of gene expression silencing by DNA methylation. P2 and P8
chondrocytes of one of these donors were transiently treated with
the chemical analog of cytidine, 5-AzaC, inhibiting DNA methyl-
ation. RNA samples were isolated and cDNA was synthesized from
total RNA with the iScript cDNA synthesis kit (Bio-Rad). quantita-
tive polymerase chain reaction (qPCR) was performed with the
MyiQ real-time PCR detection system (Bio-Rad) and glyceraldehyde
3-phosphate dehydrogenase (GAPDH) was used as internal control.
SOX9 and BMP2 expression was increased by DNA methylation in-
hibition, though COL2A1 was not affected [Fig. 1(D)]. MMP1, MMP3
and MMP13 also showed increased expression in response to
5-AzaC treatment [Fig. 1(D)]. This suggests that, at least in this
donor, expression of a set of genes is cumulatively repressed by
DNA methylation or other epigenetic mechanisms contributing to
gradual loss of the differentiated phenotype.
Ingenuity pathway analysis (IPA) software (Ingenuity Systems)
was used to identify biological processes and pathways associatedn diagram depicting the number of signiﬁcantly changed genes with 2.0 mean fold
dividual genes showing signiﬁcant changes at each passage of four donors. Expression
) Fold changes of each gene between adjacent passages (P0eP2, P2eP4, P4eP6, P6eP8).
ethylation in downregulation of gene expression. P2 or P8 chondrocytes were treated
mean with SD and analyzed by t-test. n ¼ triplicate cultures of one donor.
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genes were involved in multiple biological processes (Fig. S2).
Notably, cellular growth and proliferation, cell death and cell cycle
were signiﬁcantly changed, most obvious in P4 and P6. This is
consistent with a decrease in proliferation in monolayer culture9.
Other pathways directly related to cartilage biology, such as skel-
etal and muscular system development and function and connec-
tive tissue development also changed. The cell morphology
pathway also showed a signiﬁcant change, which is in agreement
with the phenotypic changes observed (Fig. S1A). Genes that
exhibited signiﬁcant changes in expression and are associated with
these biological processes are shown in Table S3.
To validate the microarray data, expression of a number of sig-
niﬁcantly changed genes was measured by qPCR for the same RNA
samples as used in microarray. All qPCR results and microarray data
showed strong correlation, indicating valid and successful micro-
array analysis (Fig. S3). Gene expression of ECM molecules COL2A1
and COL9A1 decreased while versican expression increased, char-
acterizing the chondrocyte dedifferentiation process. The chondro-
genic transcription factor SOX9 exhibited a steep reduction in
expression from P0 to P2. SOX9 is the key transcription activator
driving COL2A1 expression10 and overexpression of SOX9 enhances
the ability of chondrocytes to maintain their differentiated pheno-
type during expansion11. Loss of these important cartilaginous
markers may eventually lead to the loss of ability of chondrocytes toFig. 2. Involvement of ERK and BMP-2 pathways in human chondrocyte dedifferentiation. (A
western blot. Blots from one representative donor out of three donors are shown. (B) ERK re
for 24 h as indicated (in mM) in chondrocytes lentivirally transduced with luciferase promoter
donor. (C) Human chondrocytes were cultured with or without 10 mM PD98059 from P0 unt
conﬁdence intervals and analyzed by t-test. n ¼ 3 donors. (D) Human chondrocytes were cul
measured by qPCR. Data were expressed as mean with 95% conﬁdence intervals and analyze
without BMP-2 were taken at P4. Scale bar ¼ 5 mm. Images from one representative donor o
100 ng/ml BMP-2 were re-differentiated in pellet culture in chondrogenic differentiation me
without BMP-2 was measured and normalized for DNA content. Data were expressed as me
staining of GAG/sulphated GAG in pellet sections was performed. Scale bar ¼ 100 mm. Imagproduce cartilage-speciﬁc ECM and form stable cartilage in vivo.
Other transcription factors, receptors and extracellular ligands
including bone morphogenetic protein (BMP), ﬁbroblast growth
factor (FGF), insulin-like growth factor 1 and Notch changed sig-
niﬁcantly, suggesting that chondrocyte dedifferentiation may be
controlled by a complex network of pathways. The ability of chon-
drocytes to produce ECM is inversely correlated with the culture
period. While P2 chondrocytes can still be induced to produce sub-
stantial amounts of ECM, the ability of P8 chondrocytes to produce
ECM is severely compromised. This is conﬁrmed by our observation
that expression of COL2A1 and COL9A1 decreases in time. Other
markers such as BMP2 and FGFR3, which predict the capacity of
expanded human chondrocytes to form stable cartilage in vivo12,
showed continuous decrease during dedifferentiation. Matrix
degrading enzymesMMP1,MMP3 andMMP13were down-regulated.
Network analysis based on gene expression changes between P8
and P0 chondrocytes revealed the involvement of multiple signaling
pathways (Fig. S4).Keysignalingmediators suchasAkt, extracellular-
signal-regulated kinase 1/2 (ERK1/2), PI3K, p38 MAK and nuclear
factor-kB formed the cores of these networks. These signaling
pathways are at the crossroads ofmany genes shown to be gradually
but signiﬁcantlyalteredduringprolongedculturing. Thesemediators
function as upstream or downstream effectors of these changed
genes. We examined whether ERK plays a determining role in
dedifferentiation. Western blot was performed to examine the) Protein levels of collagen II, phospho(p)-ERK, total ERK, and GAPDH were detected by
porter activity was measured after treatment with different concentrations of PD98059
reporter construct. Data were expressed as meanwith SD. n¼ triplicate cultures of one
il P2. mRNA expression was measured by qPCR. Data were expressed as mean with 95%
tured with or without 100 ng/ml BMP-2 from P0 until P8. mRNA expression levels were
d by t-test. n ¼ 3 donors. (E) Light microscopic images of chondrocytes cultured with or
ut of three donors are shown. (F&G) P2 and P8 chondrocytes expanded with or without
dium. (E) GAG production of chondrocyte pellets from chondrocytes expanded with or
an with 95% conﬁdence intervals and analyzed by t-test. n ¼ 3 donors. (F) Histological
es from one representative donor out of three donors are shown.
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showed decreased expression with increasing passaging, in agree-
ment with decreased COL2A1 mRNA expression [Fig. 2(A)].
Remarkably, in culture chondrocytes from P2 onwards started to
express a smaller isoform of COL2A1 which might be a transcription
variant or cleaved protein which decreased over time [Fig. 2(A)].
There was an increase in phospho-ERK2 and a decrease in phospho-
ERK1, with ERK2 as the dominant form of ERK [Fig. 2(A)]. Total ERK2
did not show a substantial change during dedifferentiation. To test
the function of increased ERK activity during dedifferentiation, we
used the MEK1 inhibitor PD98059 which showed nearly 50% inhi-
bition of ERK activity at 10 mM [Fig. 2(B)]. We cultured human
chondrocytes from P0 to P2 in the presence of 10 mM PD98059.
COL2A1 expressionwas slightly but signiﬁcantly increased at both P0
and P2 [Fig. 2(C)], which is consistent with previous ﬁndings2,13.
However, the key chondrogenic transcription factor SOX9, important
for the maintenance of the chondrocyte phenotype11, was not
affected by ERK inhibition [Fig. 2(C)]. Gain of function analysis using
a constitutive active MEK1 has shown a role for ERK in regulating
chondrocyte proliferation and negatively regulating chondrocyte
hypertrophy inmicemodels14. This indicates a similar role forMEKe
ERK in the regulation of chondrocyte proliferation and inhibition of
the differentiation capacity of chondrocytes in prolongedmonolayer
culture. Theweak effect of ERK inhibition suggests that it may not be
the main driving factor of chondrocyte dedifferentiation. We there-
fore did not explore this further.
BMP-2 has been shown to induce the expression of chondrocyte-
speciﬁc genes, such as COL2A1 and SOX915. Our microarray and qPCR
data showed that BMP2 expression decreased during dediffer-
entiation, implying that it may be involved in loss of chondrogenic
markers and the chondrocyte phenotype. Direct stimulation of P0
human chondrocytes with BMP-2 increased the expression of
COL2A1 and SOX9, both of which showed decreased expression
during dedifferentiation (Fig. S5A). When 100 ng/ml BMP-2 was
added during extensive expansion until P8, downregulation of these
genes was counteracted at P4 and decelerated at P8, except for
COL2A1 [Fig. 2(D)]. In presence of BMP-2 a reduction in cell prolifer-
ation at P2 vs control was seen, but no signiﬁcant difference in pro-
liferation rate between control and BMP-2-expanded chondrocytes
at P8 was demonstrated (Fig. S5B). In addition, BMP-2 was able to
reduce phenotypic changes of the chondrocytes during dediffer-
entiation [Fig. 2(E)]. To testwhetheradditionofBMP-2duringculture
expansion enhances the capacity of expanded chondrocytes (P2 and
P8) to produce cartilage matrix, chondrocytes cultured with or
withoutBMP-2 inmonolayerwere re-differentiated inpellet cultures
in chondrogenic differentiation media (containing no BMP-2). GAG
productionwas signiﬁcantly higher in chondrocyte pellets formedby
cells expanded in the presence of BMP-2 at both P2 and P8 [Fig. 2(F)].
Moreover, histological staining of chondrocyte pellet sections
revealed that BMP-2 stimulated the production of cartilage-speciﬁc
ECM [Fig. 2(G)]. Taken together, these data suggest that loss of
BMP-2 expression may be an important trigger of chondrocyte
dedifferentiation. Moreover, it suggests that BMP-2 signaling seems
to be upstream of many other events in the dedifferentiation, espe-
cially at early stage of dedifferentiation.
Perturbation of the described signaling pathways during
extended culturing provides opportunities for prevention of
chondrocyte dedifferentiation and preservation of the chondrocyte
phenotype, greatly improving the outcome of ACI.
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